Spotlight
A selection of resources from across the Federation
Resource
Technical Brief: Designing and Delivering Inclusive, Rights-Based Sexual and Reproductive Healthcare to Transgender and Gender Diverse People
This technical brief outlines key recommendations across several sexual and reproductive health service areas to promote access to inclusive care for transgender and gender diverse people.
Most Popular This Week
Resource
|
Technical Brief: Designing and Delivering Inclusive, Rights-Based Sexual and Reproductive Healthcare to Transgender and Gender Diverse People
IPPF’s commitment to person-centred care is at the heart of its strategy, Come Together (2023–2028).
Resource
|
Sexual and gender-based violence services and programming overview brief
The International Planned Parenthood Federation (IPPF) is pleased to be share this sexual and gender-based violence services and programming overview document.
Resource
|
IPPF Storage Room poster
IPPF is pleased to be providing an important poster aimed at promoting safe and effective storage practices for medical supplies in your storage rooms.
Resource
|
IMAP Statement on the importance of ensuring abortion care after 13 weeks’ gestation
This statement was prepared by the International Medical Advisory Panel (IMAP) and approved in November 2024.
Resource
|
Youth-Led Digital Solutions to Advance CSE and Adolescent and Youth Friendly Services
Commonly dubbed “the digital generation”, young people are driving innovative digital solutions to lead critical conversations related to sexual and reproductive health, rights, and justice (SRHRJ)
Resource
|
2023 Annual Performance Report
Last year saw a relentless assault on human rights, leaving many feeling anxious and pessimistic about the prospects for people from all walks of life to come together.
Resource
|
IMAP Statement on Menopause
What is menopause? Menopause is a retrospective diagnosis: it is defined after a woman or person who can menstruate is amenorrheic for 12 months.
Resource
|
IMAP Statement on Person-centred Care for Sexually Transmitted Infections
Recognizing the significant global impact of sexually transmitted infections (STIs), this statement affirms IPPF’s commitment to people-centred STI care as a critical aspect of comprehensive sexual
Filter our resources by:
Resource
| 04 December 2018
Leaving no one behind: Universal health coverage and sexual and reproductive health and rights
Universal health coverage means ensuring every person has access to quality, affordable health services and plays a pivotal role in achieving global development targets. Healthy populations can better contribute socially and economically, while poor health is a major driver of poverty. Universal access to sexual and reproductive health care services is identified in the Sustainable Development Goals as an essential contributor to ensuring healthy lives and promoting well-being for all at all ages. IPPF, together with the London School of Hygiene and Tropical Medicine, undertook a literature review looking at progress to date in and challenges to achieving universal access to sexual and reproductive health and rights. The review, Leaving no one behind, is illustrated with case studies on Afghanistan, Cambodia, Kenya and Sudan. Supported by the Japan Trust Fund.
Resource
| 04 December 2018
Leaving no one behind: Universal health coverage and sexual and reproductive health and rights
Universal health coverage means ensuring every person has access to quality, affordable health services and plays a pivotal role in achieving global development targets. Healthy populations can better contribute socially and economically, while poor health is a major driver of poverty. Universal access to sexual and reproductive health care services is identified in the Sustainable Development Goals as an essential contributor to ensuring healthy lives and promoting well-being for all at all ages. IPPF, together with the London School of Hygiene and Tropical Medicine, undertook a literature review looking at progress to date in and challenges to achieving universal access to sexual and reproductive health and rights. The review, Leaving no one behind, is illustrated with case studies on Afghanistan, Cambodia, Kenya and Sudan. Supported by the Japan Trust Fund.
Resource
| 30 November 2018
Quiz: "Can I get HIV from kissing?"
World AIDS Day: “Can I get HIV from kissing?” and other questions answered1 December is World AIDS Day, an opportunity for us all to unite in the fight against HIV, to stand in solidarity with the 36.9 million people living with HIV around the world, and to commemorate those who have died from an AIDS-related illness. Over the past few decades, HIV and AIDS have been discussed a lot, but what do you really know about them? Find out in our quiz >> 1/10. True or false: HIV and AIDS are the same thing2/10. How might HIV be transmitted from one person to another?3/10. If both sexual partners have HIV, then they don’t need to worry about using condoms – true or false?4/10. There are 36.9 million people living with HIV globally. How many of them are not aware of their HIV status?5/10. Can people living with HIV safely have children?6/10. HIV only affects certain groups of people – true or false?7/10. Which of the following is the best way to prevent transmission of HIV and other STIs?8/10. True or false: If you have taken an HIV test already, then you don't need to do it again9/10. How long should you wait before going for an HIV test?10/10. What does being “undetectable” mean?Good try! If you learned something new today, scroll down to share this with friends :point_down:Pretty good! If you learned something new today, scroll down to share this with friends :point_down:Great work! If you learned something new today, scroll down to share this with friends :point_down:
Resource
| 30 November 2018
Quiz: "Can I get HIV from kissing?"
World AIDS Day: “Can I get HIV from kissing?” and other questions answered1 December is World AIDS Day, an opportunity for us all to unite in the fight against HIV, to stand in solidarity with the 36.9 million people living with HIV around the world, and to commemorate those who have died from an AIDS-related illness. Over the past few decades, HIV and AIDS have been discussed a lot, but what do you really know about them? Find out in our quiz >> 1/10. True or false: HIV and AIDS are the same thing2/10. How might HIV be transmitted from one person to another?3/10. If both sexual partners have HIV, then they don’t need to worry about using condoms – true or false?4/10. There are 36.9 million people living with HIV globally. How many of them are not aware of their HIV status?5/10. Can people living with HIV safely have children?6/10. HIV only affects certain groups of people – true or false?7/10. Which of the following is the best way to prevent transmission of HIV and other STIs?8/10. True or false: If you have taken an HIV test already, then you don't need to do it again9/10. How long should you wait before going for an HIV test?10/10. What does being “undetectable” mean?Good try! If you learned something new today, scroll down to share this with friends :point_down:Pretty good! If you learned something new today, scroll down to share this with friends :point_down:Great work! If you learned something new today, scroll down to share this with friends :point_down:
Resource
| 02 August 2018
Technical brief: Dolutegravir for women living with HIV of reproductive age
In May 2018, the World Health Organization (WHO) reported a potential safety issue concerning dolutegravir (DTG), a common first-line antiretroviral treatment drug that is used to prevent and treat HIV infections. Preliminary findings from a study in Botswana found an increased risk of neural tube defects in infants born to women taking DTG at the time of conception. As a result of this study, WHO’s revised guidance on antiretroviral regimens for treating and preventing HIV infections, released in July 2018, include a caution on use of DTG by women and adolescent girls of childbearing potential. This brief aims to provide an overview of the research to date, current WHO guidance, and recommendations for IPPF.
Resource
| 02 August 2018
Technical brief: Dolutegravir for women living with HIV of reproductive age
In May 2018, the World Health Organization (WHO) reported a potential safety issue concerning dolutegravir (DTG), a common first-line antiretroviral treatment drug that is used to prevent and treat HIV infections. Preliminary findings from a study in Botswana found an increased risk of neural tube defects in infants born to women taking DTG at the time of conception. As a result of this study, WHO’s revised guidance on antiretroviral regimens for treating and preventing HIV infections, released in July 2018, include a caution on use of DTG by women and adolescent girls of childbearing potential. This brief aims to provide an overview of the research to date, current WHO guidance, and recommendations for IPPF.
Resource
| 04 December 2018
Leaving no one behind: Universal health coverage and sexual and reproductive health and rights
Universal health coverage means ensuring every person has access to quality, affordable health services and plays a pivotal role in achieving global development targets. Healthy populations can better contribute socially and economically, while poor health is a major driver of poverty. Universal access to sexual and reproductive health care services is identified in the Sustainable Development Goals as an essential contributor to ensuring healthy lives and promoting well-being for all at all ages. IPPF, together with the London School of Hygiene and Tropical Medicine, undertook a literature review looking at progress to date in and challenges to achieving universal access to sexual and reproductive health and rights. The review, Leaving no one behind, is illustrated with case studies on Afghanistan, Cambodia, Kenya and Sudan. Supported by the Japan Trust Fund.
Resource
| 04 December 2018
Leaving no one behind: Universal health coverage and sexual and reproductive health and rights
Universal health coverage means ensuring every person has access to quality, affordable health services and plays a pivotal role in achieving global development targets. Healthy populations can better contribute socially and economically, while poor health is a major driver of poverty. Universal access to sexual and reproductive health care services is identified in the Sustainable Development Goals as an essential contributor to ensuring healthy lives and promoting well-being for all at all ages. IPPF, together with the London School of Hygiene and Tropical Medicine, undertook a literature review looking at progress to date in and challenges to achieving universal access to sexual and reproductive health and rights. The review, Leaving no one behind, is illustrated with case studies on Afghanistan, Cambodia, Kenya and Sudan. Supported by the Japan Trust Fund.
Resource
| 30 November 2018
Quiz: "Can I get HIV from kissing?"
World AIDS Day: “Can I get HIV from kissing?” and other questions answered1 December is World AIDS Day, an opportunity for us all to unite in the fight against HIV, to stand in solidarity with the 36.9 million people living with HIV around the world, and to commemorate those who have died from an AIDS-related illness. Over the past few decades, HIV and AIDS have been discussed a lot, but what do you really know about them? Find out in our quiz >> 1/10. True or false: HIV and AIDS are the same thing2/10. How might HIV be transmitted from one person to another?3/10. If both sexual partners have HIV, then they don’t need to worry about using condoms – true or false?4/10. There are 36.9 million people living with HIV globally. How many of them are not aware of their HIV status?5/10. Can people living with HIV safely have children?6/10. HIV only affects certain groups of people – true or false?7/10. Which of the following is the best way to prevent transmission of HIV and other STIs?8/10. True or false: If you have taken an HIV test already, then you don't need to do it again9/10. How long should you wait before going for an HIV test?10/10. What does being “undetectable” mean?Good try! If you learned something new today, scroll down to share this with friends :point_down:Pretty good! If you learned something new today, scroll down to share this with friends :point_down:Great work! If you learned something new today, scroll down to share this with friends :point_down:
Resource
| 30 November 2018
Quiz: "Can I get HIV from kissing?"
World AIDS Day: “Can I get HIV from kissing?” and other questions answered1 December is World AIDS Day, an opportunity for us all to unite in the fight against HIV, to stand in solidarity with the 36.9 million people living with HIV around the world, and to commemorate those who have died from an AIDS-related illness. Over the past few decades, HIV and AIDS have been discussed a lot, but what do you really know about them? Find out in our quiz >> 1/10. True or false: HIV and AIDS are the same thing2/10. How might HIV be transmitted from one person to another?3/10. If both sexual partners have HIV, then they don’t need to worry about using condoms – true or false?4/10. There are 36.9 million people living with HIV globally. How many of them are not aware of their HIV status?5/10. Can people living with HIV safely have children?6/10. HIV only affects certain groups of people – true or false?7/10. Which of the following is the best way to prevent transmission of HIV and other STIs?8/10. True or false: If you have taken an HIV test already, then you don't need to do it again9/10. How long should you wait before going for an HIV test?10/10. What does being “undetectable” mean?Good try! If you learned something new today, scroll down to share this with friends :point_down:Pretty good! If you learned something new today, scroll down to share this with friends :point_down:Great work! If you learned something new today, scroll down to share this with friends :point_down:
Resource
| 02 August 2018
Technical brief: Dolutegravir for women living with HIV of reproductive age
In May 2018, the World Health Organization (WHO) reported a potential safety issue concerning dolutegravir (DTG), a common first-line antiretroviral treatment drug that is used to prevent and treat HIV infections. Preliminary findings from a study in Botswana found an increased risk of neural tube defects in infants born to women taking DTG at the time of conception. As a result of this study, WHO’s revised guidance on antiretroviral regimens for treating and preventing HIV infections, released in July 2018, include a caution on use of DTG by women and adolescent girls of childbearing potential. This brief aims to provide an overview of the research to date, current WHO guidance, and recommendations for IPPF.
Resource
| 02 August 2018
Technical brief: Dolutegravir for women living with HIV of reproductive age
In May 2018, the World Health Organization (WHO) reported a potential safety issue concerning dolutegravir (DTG), a common first-line antiretroviral treatment drug that is used to prevent and treat HIV infections. Preliminary findings from a study in Botswana found an increased risk of neural tube defects in infants born to women taking DTG at the time of conception. As a result of this study, WHO’s revised guidance on antiretroviral regimens for treating and preventing HIV infections, released in July 2018, include a caution on use of DTG by women and adolescent girls of childbearing potential. This brief aims to provide an overview of the research to date, current WHO guidance, and recommendations for IPPF.
